<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page3_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page3_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>Glyceraldehyde 3-phosphate dehydrogenase (EC 1</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>28</o:Revision>
  <o:TotalTime>66</o:TotalTime>
  <o:Created>2004-02-02T17:28:00Z</o:Created>
  <o:LastSaved>2004-02-04T14:32:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1077</o:Words>
  <o:Characters>6142</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>51</o:Lines>
  <o:Paragraphs>12</o:Paragraphs>
  <o:CharactersWithSpaces>7542</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:red;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin:0cm;
	margin-bottom:.0001pt;
	text-indent:36.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page3_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page3_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Enzymes of Glycolysis<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><u><span style='color:navy'>PHASE II:</span></u><span style='color:navy'><span
style="mso-spacerun: yes">  </span>The enzymes in detail<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>The second
phase of glycolysis involves the extraction of energy in the form of 4 ATP per
molecule of glucose, a net gain of 2 ATP molecules.<span style="mso-spacerun:
yes">  </span>The product of glycolysis, pyruvate, can then be further broken
either aerobically ( to carbon dioxide and water through the TCA cycle) or
anaerobically (to lactate or alcohol).</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Glyceraldehyde 3-phosphate dehydrogenase<span
style="mso-spacerun: yes">  </span>(</span><span lang=IT style='color:navy;
mso-ansi-language:IT'><a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?1.2.1.12" title="ENZYME database"><span
lang=EN-US style='mso-ansi-language:EN-US'>EC 1.2.1.12</span></a></span><span
style='color:navy'>)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes">  </span>Glyceraldehyde-3-phosphate
(G3P) +NAD<sup><span style='font-size:9.0pt;mso-bidi-font-size:12.0pt'>+</span></sup>
+ Pi <span style='font-family:Wingdings;mso-ascii-font-family:"Times New Roman";
mso-hansi-font-family:"Times New Roman";mso-char-type:symbol;mso-symbol-font-family:
Wingdings'><span style='mso-char-type:symbol;mso-symbol-font-family:Wingdings'>à</span></span>
1,3-Bisphosphoglycerate (1,3BPG) + NADH + H<sup><span style='font-size:9.0pt;
mso-bidi-font-size:12.0pt'>+</span></sup></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plays an
important role in glycolysis and gluconeogenesis by reversibly catalysing the
oxidation and phosphorylation of G3P to the energy-rich intermediate
1,3BPG.<span style="mso-spacerun: yes">  </span>NAD<sup><span style='font-size:
9.0pt;mso-bidi-font-size:12.0pt'>+</span></sup> is a co-substrate for this
reaction.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-indent:36.0pt'><span style='mso-bidi-font-size:
10.0pt;color:black'>GAPDH displays diverse non-glycolytic functions as well,
its role depending upon its subcellular location.<span style="mso-spacerun:
yes">  </span>For instance, the translocation of GAPDH to the nucleus acts as a
signalling mechanism for programmed cell death, or apoptosis.<span
style="mso-spacerun: yes">  </span>The accumulation of GAPDH within the nucleus
is involved in the induction of apoptosis, where GAPDH functions in the activation
of transcription.<span style="mso-spacerun: yes">  </span>The presence of GAPDH
is associated with the synthesis of pro-apoptotic proteins like BAX, c-JUN and
GAPDH itself.<o:p></o:p></span></p>

<p class=MsoNormal style='text-indent:36.0pt'><span style='mso-bidi-font-size:
10.0pt;color:black'>GAPDH has been implicated in certain neurological diseases:
GAPDH is able to bind to the gene products from neurodegenerative disorders
such as Huntington’s disease, Alzheimer’s disease, Parkinson’s disease and
Machado-Joseph disease through stretches encoded by their CAG repeats.<span
style="mso-spacerun: yes">  </span>Abnormal neuronal apoptosis is associated
with these diseases.<span style="mso-spacerun: yes">  </span>Propargylamines
such as deprenyl increase neuronal survival by interfering with apoptosis
signalling pathways via their binding to GAPDH, which decreases the synthesis
of pro-apoptotic proteins.<o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Phosphoglycerate kinase (<a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?2.7.2.3" title="ENZYME database">EC
2.7.2.3</a>)</span><span style='font-family:"Times New Roman";color:navy'><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>1,3-Bisphosphoglycerate (1,3BPG) + ADP <span style='font-family:Wingdings;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:
symbol;mso-symbol-font-family:Wingdings'>à</span></span> 3-Phosphoglycerate
(3PG) + ATP</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Phosphoglycerate
kinase (PGK) is an enzyme that reversibly catalyses the formation of ATP to
ADP, using one of the high-energy phosphate groups from 1,3BPG.<span
style="mso-spacerun: yes">  </span>The reaction forms two ATP molecules per
glucose (one per 1,3BPG molecule), which compensates for the expenditure of 2
ATP in phase I of glycolysis.<span style="mso-spacerun: yes">  </span>The ATP
is made by substrate-level phosphorylation, where a phosphate group is transferred
from 1,3BPG directly to ADP. <span style="mso-spacerun: yes"> </span>This
reaction is essential in most cells for the generation of ATP in aerobes, for
fermentation in anaerobes and for carbon fixation in plants. </p>

<p class=MsoNormal style='text-indent:36.0pt'>Deficiencies in PGK are
associated with haemolytic anaemia, myopathy, central nervous system disorder
and growth retardation.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Phosphoglycerate mutase (<a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?5.4.2.1" title="ENZYME database">EC
5.4.2.1</a>)</span><span style='font-family:"Times New Roman";color:navy'><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>3-Phosphoglycerate (3PG) <span style='font-family:Wingdings;mso-ascii-font-family:
"Times New Roman";mso-hansi-font-family:"Times New Roman";mso-char-type:symbol;
mso-symbol-font-family:Wingdings'><span style='mso-char-type:symbol;mso-symbol-font-family:
Wingdings'>à</span></span> 2-Phosphoglycerate (2PG)</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-indent:36.0pt'>Phosphoglycerate mutase (PGAM)
catalyses the transfer of the phospho group from the C3 position to the C2
position, in preparation for the synthesis of ATP.<span style="mso-spacerun:
yes">  </span>PGAM enzymes from different sources exhibit different reaction
mechanisms.<span style="mso-spacerun: yes">  </span>For instance, some PGAM
enzymes (vertebrates, fungi, certain bacteria) use 2,3-bisphophoglycerate as a
cofactor to phosphorylate a serine residue to prime the reaction, whereas other
PGAM enzymes (plants, certain invertebrates, algae, certain bacteria) carry out
intramolecular phosphoryl group transfer via an active site residue without the
need of a cofactor.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Deficiencies
in PGAM can cause acute muscle dysfunction with exercise intolerance and muscle
breakdown.<span style='mso-bidi-font-size:10.0pt;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Enolase (<a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?4.2.1.11" title="ENZYME database">EC
4.2.1.11</a>)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>2-Phosphoglycerate (2PG) <span lang=FR style='font-family:Wingdings;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-ansi-language:FR;mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span
style='mso-char-type:symbol;mso-symbol-font-family:Wingdings'>à</span></span>
Phosphoenolpyruvate (PEP) + H2O</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-indent:36.0pt'><span style='mso-bidi-font-size:
10.0pt;color:black'>Enolase (phosphopyruvate hydratase) </span>is an essential
glycolytic enzyme that catalyses the reversible dehydration of
2-phosphoglycerate to the high-energy intermediate phosphoenolpyruvate.<span
style="mso-spacerun: yes">  </span>Enolase is strongly inhibited by fluoride
ions, which forms a fluorophosphate complex with magnesium at the active
site.<span style="mso-spacerun: yes">  </span>In vertebrates, there are 3
different, tissue-specific isozymes, designated alpha, beta and gamma. Alpha is
present in most tissues, beta is localised in muscle tissue, and gamma is found
only in nervous tissue.<span style="mso-spacerun: yes">  </span>The functional
enzyme exists as homo- or hetero-dimers of the different isozymes.<span
style="mso-spacerun: yes">  </span>In immature organs and in adult liver, it is
usually an alpha homodimer, in adult skeletal muscle, a beta homodimer, and in
adult neurons, a gamma homodimer. In developing muscle, it is usually an
alpha/beta heterodimer, and in the developing nervous system, an alpha/gamma
heterodimer.<span style='mso-bidi-font-size:10.0pt;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='text-indent:36.0pt'>Neuron-specific enolase is released
in a variety of neurological diseases, such as multiple sclerosis and after
seizures or acute stroke.<span style="mso-spacerun: yes">  </span>Several
tumour cells have also been found positive for neuron-specific enolase.<span
style="mso-spacerun: yes">  </span>Beta-enolase deficiency is associated with
glycogenosis type XIII defect.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span lang=FI style='color:navy;mso-ansi-language:FI'>Pyruvate kinase (</span><span
style='color:navy'><a href="http://us.expasy.org/cgi-bin/nicezyme.pl?2.7.1.40"
title="ENZYME database"><span lang=FI style='mso-ansi-language:FI'>EC 2.7.1.40</span></a></span><span
lang=FI style='color:navy;mso-ansi-language:FI'>)</span><span lang=FI
style='font-family:"Times New Roman";color:navy;mso-ansi-language:FI'><o:p></o:p></span></h1>

<p class=MsoNormal><span lang=FI style='mso-ansi-language:FI'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>Phosphoenolpyruvate (PEP) + ADP <span lang=FR style='font-family:Wingdings;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-ansi-language:FR;mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span
style='mso-char-type:symbol;mso-symbol-font-family:Wingdings'>à</span></span>
Pyruvate + ATP</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-indent:36.0pt'>Pyruvate kinase (PK) catalyses
the final step in glycolysis, the conversion of PEP to pyruvate with the
concomitant transfer of the high-energy phosphate group from PEP to ADP,
thereby generating ATP.<span style="mso-spacerun: yes">  </span>PK requires
both magnesium and potassium for activity.<span style="mso-spacerun: yes"> 
</span>In vertebrates, there are four tissue-specific isozymes: L (liver), R
(red cells), M1 (muscle, heart and brain), and M2 (early foetal tissue). In
plants PK exists as cytoplasmic and plastid isozymes, while most bacteria and
lower eukaryotes have one form, except in certain bacteria, such as <i>Escherichia
coli</i>, that have two isozymes.</p>

<p class=MsoBodyTextIndent>PK helps control the rate of glycolysis, along with
phosphofructokinase and hexokinase.<span style="mso-spacerun: yes">  </span>PK
possesses allosteric sites for numerous effectors, yet the isozymes respond
differently, in keeping with their different tissue distributions.<span
style="mso-spacerun: yes">  </span>The activity of L-type (liver) PK is
increased by fructose-1,6-bisphosphate (F1,6BP) and lowered by ATP and alanine
(gluconeogenic precursor), therefore when glucose levels are high, glycolysis
is promoted, and when levels are low, gluconeogenesis is promoted.<span
style="mso-spacerun: yes">  </span>L-type PK is also hormonally regulated,
being activated by insulin and inhibited by glucagon, which covalently modifies
the PK enzyme.<span style="mso-spacerun: yes">  </span>M1-type (muscle, brain)
PK is inhibited by ATP, but F1,6BP and alanine have no effect, which correlates
with the function of muscle and brain, as opposed to the liver. </p>

<p class=MsoNormal style='text-indent:36.0pt'>The pyruvate produced by PK feeds
into a number of different metabolic pathways.<span style="mso-spacerun: yes"> 
</span>Under aerobic conditions, pyruvate can be transported to the
mitochondria, where it enters the TCA cycle and is further broken down to
produce considerably more ATP through oxidative phosphorylation.<span
style="mso-spacerun: yes">  </span>Alternatively, pyruvate can be anaerobically
reduced to lactate in cells lacking mitochondria, or under hypoxic conditions,
such as found in hard working muscle tissues.<span style="mso-spacerun: yes"> 
</span>Other by-products of anaerobic breakdown of pyruvate include ethanol
during fermentation by yeast</p>

<p class=MsoNormal><span style='color:red'><span style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<h1 align=center style='text-align:center'><span style='font-weight:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page4.htm">What InterPro tells
us:<span style="mso-spacerun: yes">  </span>phase I enzymes</a><o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-weight:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page2.htm">Phase I:<span
style="mso-spacerun: yes">  </span>the enzymes in detail</a><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
